Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease

Experimental Parasitology

Volumn 108, Issue 1-2, 2004, Pages 24-31

  Villarreal, Diana ^a   Barnabé, Christian ^a   Sereno, Denis ^b   Tibayrenc, Michel ^a  

^a Genet Evol Maladies I   (France)

^b 911 Ave Agropolis B   (France)

Author keywords

3 (4,5 dimethylthiazol 2 yl) 2,5 diphenyl 2H tetrazolium bromide; dimethyl sulphoxide; discrete typing unit; DMSO; DTU; IC 50; inhibitory concentration; MLEE; MTT; multilocus enzyme electrophoresis; PMS; random amplified polymorphic DNA; RAPD

Indexed keywords

BENZNIDAZOLE;

ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG SENSITIVITY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC VARIABILITY; IC 50; IN VITRO STUDY; MULTILOCUS ENZYME ELECTROPHORESIS; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; TRYPANOSOMA CRUZI;

ANALYSIS OF VARIANCE; ANIMALS; CHAGAS DISEASE; ELECTROPHORESIS, CELLULOSE ACETATE; FLOW CYTOMETRY; HUMANS; INHIBITORY CONCENTRATION 50; ISOENZYMES; NITROIMIDAZOLES; PARASITIC SENSITIVITY TESTS; PHYLOGENY; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; VARIATION (GENETICS);

TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 7444247888     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exppara.2004.07.001     Document Type: Article

References (61)

1. S.G. Andrade Tentative for grouping different Trypanosoma cruzi strains in some types Revista do Instituto de Medicina Tropical de São Paulo 18 1976 140 141
2. S.G. Andrade, and J.B. Magalhães Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology Revista da Sociedade Brasileira de Medicina Tropical 30 1997 27 35
3. S.G. Andrade, J.B. Magalhães, and A.L. Pontes Evaluation of chemotherapy with Benznidazole and Nifurtimox in mice infected with Trypanosoma cruzi strains of different types Bulletin of the World Health Organization 63 1985 721 726
4. S.G. Andrade, A. Rassi, J.B. Magalhães, F. Ferriolli Filho, and A.O. Luquetti Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains Transactions of the Royal Society of Tropical Medicine and Hygiene 86 1992 624 626
5. C. Barnabã, S. Brisse, and M. Tibayrenc Population structure and genetic typing of Trypanosoma cruzi, the agent of Chagas disease: a multilocus enzyme electrophoresis approach Parasitology 120 2000 513 526
6. S. Ben Abderrazak, F. Guerrini, F. Mathieu-Daudã, P. Truc, K. Neubauer, K. Lewicka, C. Barnabã, and M. Tibayrenc Isoenzyme electrophoresis for parasite characterisation J.E. Hyde Methods in Molecular Biology 1993 Humana Press New York 361 382
7. A.R. Bogliolo, L. Lauriapires, and W.C. Gibson Polymorphisms in Trypanosoma cruzi: evidence of genetic recombination Acta Tropica 61 1996 31 40
8. Z. Brener Recent advances in chemotherapy of Chagas disease Memórias do Instituto Oswaldo Cruz 79 1984 149 155
9. Z. Brener, C.A.G. Costa, and C.A. Chiari Differences in susceptibility of Trypanosoma cruzi strains to active chemotherapeutic agents Revista do Instituto de Medicina Tropical de São Paulo 18 1976 450 455
10. S. Brisse, C. Barnabã, and M. Tibayrenc Identification of six Trypanosoma cruzi phylogenetic lineages by random amplified polymorphic DNA and multilocus enzyme electrophoresis International Journal for Parasitology 30 2000 35 44
11. S. Brisse, J. Henriksson, C. Barnabã, E.J.P. Douzery, D. Berkvens, M. Serrano, M.R.C. De Carvalho, G.A. Buck, J.C. Dujardin, and M. Tibayrenc Evidence for genetic exchange and hybridization in Trypanosoma cruzi based on nucleotide sequences and molecular karyotype Infection, Genetics and Evolution 2 3 2003 173 183
12. F.S. Buckner, A.J. Wilson, T.C. White, and W.C. Van Voorhis Induction de la resistance to azoles drug in Trypanosoma cruzi Antimicrobial Agents and Chemotherapy 42 12 1998 3245 3250
13. M. De Lana, A.S. Pinto, C. Barnabé, V. Quesney, S. Noël, and M. Tibayrenc Trypanosoma cruzi: compared vectorial transmissibility of three major clonal genotypes by Triatoma infestans Experimental Parasitology 89 1998 1 5
14. G. Delgado, F. Puentes, A. Moreno, and M.E. Patarroyo Flow cytometry, a useful tool for detecting the lethal effect of Pentamidine on Leishmania viannia complex promastigote forms Pharmacological Research 44 2001 281 286
15. J.A. Dvorak The natural heterogeneity of Trypanosoma cruzi: biological and medical implications Journal of Cellular Biochemistry 24 1984 357 371
16. J.A. Dvorak, D.L. Hartman, and M.A. Miles Trypanosoma cruzi: correlation of growth kinetics to zymodeme type in clones derived from various sources Journal of Protozoology 27 1980 472 474
17. J.C. Engel, G.C. Torres, I. Hsieh, P.S. Doyle, and J.H. McKerrow Upregulation of the secretory pathway in cysteine protease inhibitor-resistant Trypanosoma cruzi Journal of Cell Science 113 2000 1345 1354
18. L.S. Filardi, and Z. Brener Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease Transactions of the Royal Society of Tropical Medicine and Hygiene 81 1987 755 759
19. M.W. Gaunt, M. Yeo, I.A. Frame, J.R. Stothard, H.J. Carrasco, M.C. Taylor, M.S. Solis, P. Veazey, G.A.J. Miles, N. Acosta, A.A. Rojas de, and M.A. Miles Mechanism of genetic exchange in American trypanosomes Nature 421 2003 936 939
20. Hills, M., Hudson, C., Smith, P.G., 1986. Global monitoring of the resistance of malarial parasites to drugs: statistical treatment of micro-test data. Working paper 2.8.5 Informal consultation on the epidemiology of drug resistance of malaria parasites, Geneva, Switzerland
21. P. Jaccard Nouvelles recherches sur la distribution florale Bulletin de la Société Vaudoise de Sciences Naturelles 44 1908 223 270
22. Kamau, S.W., Nunez, R., Grimm, F., 2001. Flow cytometry analysis of the effect of Allopurinol and the dinitroaniline compound (Chloralin) on the viability and proliferation of Leishmania infantun promastigotes. BMC Pharmacol. 1(1), 1. Available from: 〈 http://www.biomedcentral.com/1471-2210/1/1 〉
23. M. Khaw, and C.B. Panosian Human antiprotozoal therapy: past, present, and future Clinical Microbiology Reviews 8 1995 427 439
24. S.M. Kirk, R.F. Schell, A.V. Moore, S.M. Callister, and G.H. Mazurek Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to Ethambutol, Isoniazid, and Rifampin in 24 hours Journal of Clinical Microbiology 36 1998 1568 1573
25. J.P. Laurent, C. Barnabé, V. Quesney, S. Noël, and M. Tibayrenc Impact of clonal evolution on the biological diversity of Trypanosoma cruzi Parasitology 114 1997 213 218
26. A.M. Macedo, and S.D.J. Pena Genetic variability of Trypanosoma cruzi: implications for the pathogenesis of Chagas disease Parasitology Today 14 1998 119 124
27. N. Mantel The detection of disease clustering and a generalized regression approach Cancer Research 27 1967 209 220
28. J.D. Maya, Y. Repetto, M. AgosÃ-n, J.M. Ojeda, R. Tellez, C. Gaule, and A. Morello Effects of Nifurtimox and Benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi Molecular and Biochemical Parasitology 86 1997 101 106
29. H. Momen Taxonomy of Trypanosoma cruzi: a commentary on characterization and nomenclature Memòrias do Instituto Oswaldo Cruz 94 Suppl. 1 1999 181 184
30. C. Moncada, Y. Repetto, J. Aldunate, M.E. Letelier, and A. Morello Role of glutathione in the susceptibility of Trypanosoma cruzi to drugs Comparative Biochemistry and Physiology C 94 1989 87 91
31. A.V. Moore, S.M. Kirk, S.M. Callister, G.H. Mazurek, and R.F. Schell Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry Journal of Clinical Microbiology 37 1999 479 483
32. S. Muelas-Serrano, J.J. Nogal-Ruiz, and A. Gòmez-Barrio Setting of a colorimetric method to determine the viability of Trypanosoma cruzi epimastigotes Parasitology Research 86 2000 999 1002
33. R.A Neal, and J. van Bueren Comparative studies of drug susceptibilities of five strains of Trypanosoma cruzi in vivo and in vitro Transactions of the Royal Society of Tropical Medicine and Hygiene 82 1988 709 714
34. T. Nozaki, and J.A. Dvorak Intraspecific diversity in the response of Trypanosoma cruzi to environmental stress Journal of Parasitology 79 1993 451 454
35. M. Ouellette, and B. Papadopoulou Mechanisms of drug resistance in Leishmania Parasitology Today 9 1993 150 153
36. R.D.M. Page TREEVIEW: an application to display phylogenetic trees on personal computers Bioinformatics 12 1996 357 358
37. Y. Repetto, E. Opazo, J.D. Maya, M. AgosÃ-n, and A. Morello Glutathione and Trypanothione in several strains of Trypanosoma cruzi: effect of drugs Comparative Biochemistry and Physiology B 115 1996 281 285
38. Revollo, S., 1995. Impact de l'évolution clonale de Trypanosoma cruzi, agent de la maladie de Chagas, sur certaines propriétés biologiques médicalement importantes du parasite. Thèse de Doctorat. Université de Montpellier II, France. p. 209
39. S. Revollo, B. Oury, J.P. Laurent, C. Barnabé, V. Quesney, V. Carriére, S. Noël, and M. Tibayrenc Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties Experimental Parasitology 89 1998 30 39
40. J. Rodrigues Coura, and S.L. de Castro A critical review on Chagas disease chemotherapy Memòrias do Instituto Oswaldo Cruz 97 2002 3 24
41. N. Saitou, and M. Nei The neighbor-joining method: a new method for reconstructing phylogenetic trees Molecular Biology and Evolution 4 1987 406 425
42. P.H.A. Sneath, and R.R. Sokal Numerical taxonomy D. Kennedy R.B. Park The principle and practice of numerical classification 1973 Freeman San Francisco 537
43. J.R. Stothard, I.A. Frame, and M.A. Miles Genetic diversity and genetic exchange in Trypanosoma cruzi: dual drug-resistant "progeny" from episomal transformats Memòrias do Instituto Oswaldo Cruz 94 Suppl. 1 1999 189 193
44. A.R. Teixeira, M.A. Calixto, and M.L. Teixeira Chagas disease: carcinogenic activity on the trypanosomal nitroarenes in mice Mutation Research 305 1994 189 196
45. J. Thioulouse, D. Chessel, S. Dolédec, and J.M. Olivier ADE-4: a multivariate analysis and graphical display software Statistics and Computing 7 1997 75 83
46. M. Tibayrenc Population genetics of parasitic protozoa and other organisms Advances in Parasitology 36 1995 47 115
47. M. Tibayrenc Towards a unified evolutionary genetics of microorganisms Annual Review of Microbiology 50 1996 401 429
48. M. Tibayrenc Genetic epidemiology of parasitic protozoa and other infectious agents: the need for an integrated approach International Journal for Parasitology 28 1998 85 104
49. M. Tibayrenc, and F.J. Ayala Isozyme variability in Trypanosoma cruzi, the agent of Chagas’ disease: genetical, taxonomical, and epidemiological significance Evolution 42 1988 277 292
50. M. Tibayrenc, and F.J. Ayala Evolutionary genetics of Trypanosoma and Leishmania Microbes and Infection 1 1999 465 472
51. M. Tibayrenc, K. Neubauer, C. Barnabé, F. Guerrini, D. Skarecky, and F.J. Ayala Genetic characterization of six parasitic protozoa: parity between random-primer DNA typing and multilocus enzyme electrophoresis Proceedings of the National Academy of Sciences USA 90 4 1993 1335 1339
52. M. Tibayrenc, P. Ward, A. Moya, and F.J. Ayala Natural populations of Trypanosoma cruzi, the agent of Chagas' disease, have a complex multiclonal structure Proceedings of the National Academy of Sciences USA 83 1986 115 119
53. M.J.O. Toledo, A.L.F. Guilherme, J.C. Silva, M.V. Gasperi, A.P. Mendes, M.L. Gomes, and S.M. Araújo Trypanosoma cruzi: chemotherapy with Benznidazole in mice inoculated with strains from Paraná state and from different endemic areas of Brazil Revista do Instituto de Medicina Tropical de São Paulo 39 1997 283 290
54. M.J.O. Toledo, M. de Lana, C.M. Carneiro, M.T. Bahia, G.L.L. Machado-Coelho, V.M. Veloso, C. Barnabé, M. Tibayrenc, and W.L. Tafuri Impact of Trypanosoma cruzi clonal evolution on its biological properties in mice Experimental Parasitology 100 2002 161 172
55. M.J. Toledo, M.T. Bahia, C.M. Carneiro, O.A. Martins-Filho, M. Tibayrenc, C. Barnabé, W.L. Tafuri, and M. de Lana Chemotherapy with Benznidazole and Itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes Antimicrobial Agents and Chemotherapy 47 2003 223 230
56. B. Ullman Multidrug resistance and P-glycoproteins in parasitic protozoa Journal of Bioenergetics and Biomembranes 27 1995 77 84
57. J.A. Upcroft, and P. Upcroft Drug resistance and Giardia Parasitology Today 9 1993 187 190
58. V.M. Veloso, C.M. Carneiro, M.J.O. Toledo, M. de Lana, E. Chiari, W.L. Tafuri, and M.T. Bahia Variation in susceptibility to Benznidazole in isolates derived from Trypanosoma cruzi parental strains Memòrias do Instituto Oswaldo Cruz 96 2001 1005 1011
59. B. Vergnes, D. Sereno, N. Madjidian-Sereno, J.-L. Lemesre, and A. Ouaissi Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death Gene 296 2002 139 150
60. C.M. Wilson, A.E. Serrano, A. Wasley, M.P. Bogenschutz, A.H. Shankar, and D.F. Wirth Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum Science 244 1989 1184 1186
61. WHO-World Health Organization, 1991. Control of Chagas Disease. Technical Report No. 811. WHO, Geneva, Switzerland. pp. 150